OPK

OPKO Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.020
0.000
0.00%
Pre Market: 4.080 +0.06 +1.49% 06:00 07/13 EDT
OPEN
3.960
PREV CLOSE
4.020
HIGH
4.140
LOW
3.910
VOLUME
9.61M
TURNOVER
--
52 WEEK HIGH
4.270
52 WEEK LOW
1.117
MARKET CAP
2.69B
P/E (TTM)
-8.3663
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average OPK stock price target is 4.950 with a high estimate of 6.00 and a low estimate of 3.800.

EPS

OPK News

More
OPKO Health (OPK) Flat As Market Gains: What You Should Know
Zacks · 2d ago
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)
Benzinga · 2d ago
Why OPKO Health (OPK) Stock Might be a Great Pick
Zacks · 3d ago
Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees
PR Newswire · 3d ago
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8)
Benzinga · 3d ago
XBI: Not Everybody Can Be A Hero
Seeking Alpha - Article · 5d ago
Here's Why You Should Invest in OPKO Health (OPK) Stock Now
Zacks · 6d ago
Is OPKO Health (OPK) Outperforming Other Medical Stocks This Year?
Zacks · 07/03 16:30

Industry

Pharmaceuticals
-0.31%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About OPK

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health), GeneDx and Laboratorio Bueno Salud. As of December 31, 2016, it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Biologics, hGH-CTP, Factor VII, Oxyntomodulin, active pharmaceutical ingredients, Oligonucleotide Therapeutics, NK-1 Program, Asthma and chronic obstructive pulmonary disease.
More

Webull offers kinds of Opko Health Inc. stock information, including NASDAQ:OPK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OPK stock methods without spending real money on the virtual paper trading platform.